Sigma’s LEAPP to success

SIGMA Healthcare’s

LEAPP Dispensary Excellence program (PD 09

Mar 2017) is generating significant increases in pharmacy services and sales for the 46 pharmacies nationally who have taken up the program.

The LEAPP program (Leadership, Engagement, Analytics, People and Physicals), which runs over 24 weeks, aims to “deliver workflow efficiencies that provide pharmacists the time and skills to optimise engagement with their patients,” according to Sigma ceo Mark Hooper.

Sigma launched the program at the beginning of 2017, enrolling 46 pharmacies nationally (31 Amcal and 15 Guardian) in two intakes.

Headline results of those who participated in the program include: Meds Checks/clinical interventions recording up by over 100%, SMS Script Reminder Service patient sign-ups increased by over 50%, sales and gross profit growth of up to 10% in just six months, and script numbers up 4% on average.

Hooper said LEAPP has been developed to “enhance the quality of the patient experience through a unique pharmacist-led advicedriven service offering, which is a core value of Amcal and Guardian.

“A dispensary program of this depth, scope and professional support is a first for Australia’s pharmacy sector.’’

The program takes a multi-faceted approach, focusing on increased pharmacist availability and by improving quality of engagement with patients through coaching in pharmacist counselling.

“Amcal and Guardian are already two of the most trusted brands in the country, and we know customers value the expertise they receive when they talk to their pharmacist,” he said.

Vanessa Lontos, Sigma national dispensary learning & development manager, said participating pharmacies had been “amazed with the outcomes on both a professional and business level”.

The next LEAPP intake for Amcal and Guardian pharmacies will run from Feb 2018, followed by a further group starting in Jun 2018.